Supplement Table 1. Baseline characteristics of study population grouping by different types of myocardial infarction (MI, included STEMI and NSTEMI).
STEMI (N = 116) | NSTEMI (N = 214) | p value | |
Age (years) | 69.2 ± 15.8 | 72.7 ± 14.8 | 0.052 |
Male, n (%) | 94 (81.0) | 152 (72.0) | 0.162 |
SBP (mmHg) | 131 ± 34.4 | 135 ± 28.3 | 0.086 |
Heart rate (beats/min) | 85.0 ± 21.0 | 85.0 ± 20.6 | 0.590 |
Respiratory rate (rates/min) | 20.3 ± 4.1 | 20.5 ± 3.6 | 0.582 |
Body temperature (°C) | 36.4 ± 0.6 | 36.2 ± 1.1 | 0.500 |
Current smoker, n (%) | 27 (23.2) | 41 (19.2) | 0.583 |
Diabetes mellitus, n (%) | 44 (37.9) | 102 (47.7) | 0.089 |
Hypertension, n (%) | 74 (63.8) | 160 (74.7) | 0.036 |
Heart failure, n (%) | 5 (4.3) | 214 (14.5) | 0.005 |
Medications, n (%) | |||
Aspirin | 24 (20.7) | 61 (28.5) | 0.134 |
Beta blocker | 18 (15.5) | 55 (25.7) | 0.038 |
ACEi | 10 (8.6) | 24 (11.2) | 0.473 |
Laboratory data | |||
White blood cell (103/cumm) | 13.4 ± 21.5 | 11.1 ± 12.2 | 0.161 |
Segment (%) | 74.5 ± 13.7 | 75.0 ± 12.1 | 0.531 |
Hemoglobin (g/dl) | 13.0 ± 2.5 | 12.1 ± 2.7 | 0.433 |
Creatitine (mg/dl) | 1.6 ± 1.3 | 2.3 ± 1.6 | 0.001 |
CRP (mg/dl) | 4.4 ± 5.8 | 3.9 ± 6.1 | 0.556 |
Initial CK (mg/dL) | 471.5 ± 1043.0 | 326.2 ± 541.0 | 0.010 |
Peak CK (mg/dl) | 1646.6 ± 2672.2 | 789.7 ± 1541.2 | 0.001 |
LVEF (%) | 49.0 ± 11.1 | 47.9 ± 11.9 | 0.449 |
Location of vascular lesions | 0.482 | ||
LAD | 69 (59.5) | 111 (51.9) | |
LCX | 56 (48.3) | 103 (48.1) | |
RCA | 64 (55.2) | 114 (53.3) | |
Total revascularization | 48 (41.4) | 40 (18.7) | 0.032 |
CIN after procedure | 4 (3.4) | 15 (7.0) | 0.185 |
ACEi, angiotensin converting enzyme inhibitor; CABG, coronary artery bypass surgery; CIN, contrast induce nephropathy; CK, creatine kinase; CRP, C-reactive protein; LAD, left anterior descending artery; LCX, left circumflex artery; LVEF, left ventricular ejection fraction; NSTEMI, non-ST elevation MI; RCA, right coronary artery; SBP, systolic blood pressure; STEMI, ST elevation MI.